ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2019年12月19日 17時00分
TransCanna Wins 1st and 3rd place at the 2019 Emerald Cup for SolDaze CBD Edibles
Vancouver, BC, 2019年12月19日 - (JCN Newswire) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that SolDaze Snacks won first place for their tropical mango fruit bites and third place for their strawberry mango fruit bites in the CBD edible category at the 2019 Emerald Cup. SolDaze has won multiple times at the Emerald Cup, including in 2018 for its THC edibles.
"We had great customer response to our CBD edibles," stated Shawn Shevlin, manager of the SolDaze brand for TransCanna. "Customers loved the taste, price point and the fact that they are organic and naturally sweetened. It was a great honor to be on the stage and to be recognized by some of the true trailblazers in the cannabis industry."
The Emerald Cup is Northern California's premier cannabis event which advances the concept of sustainable, outdoor farming. The event has a reputation which is firmly solidified as the largest, most-respected, outdoor cannabis competition in the world.
"Congratulations to our team for their hard work to bring these award-winning SolDaze products to market. There is a tremendous upside for TransCanna with our CBD edibles in California and across the US, as the CBD market opens up nationwide," said Steve Giblin, president and CEO of TransCanna. "We have already expanded our distribution network to meet anticipated demand."
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a California based, Canadian listed, company building Cannabis focused brands for the California lifestyle, through its wholly-owned California subsidiaries.
For further information, please visit the Company's website at www.transcanna.com or email the Company at
info@transcanna.com
.
On behalf of the Board of Directors
Steve Giblin
President
604-609-6199
The information in this news release includes certain information and statements about management's view of future events, expectations, plans, and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Forward-looking statements in this news. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
To view the source version of this press release, please visit
https://www.newsfilecorp.com/release/50933
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Hitachi Advances Strategic Alliance with Google Cloud to Empower Frontline Workers with Field-Specific AI Agents
Oct 11, 2025 00:58 JST
Honda Issues Integrated Report - "Honda Report 2025"
Oct 11, 2025 00:46 JST
DENSO's Electrification Products Adopted for TOYOTA's New "bZ4X"
Oct 11, 2025 00:21 JST
Newly developed eAxle adopted for TOYOTA's new "bZ4X"
Oct 11, 2025 00:08 JST
MHIET and MHI-TC Complete Delivery of First "COORDY" Controller Providing Optimized Control of Multiple Power Sources
Oct 10, 2025 23:47 JST
Fujitsu migrates service operations virtualization platform used by 3,000 companies to Nutanix and introduces migration support services utilizing proven expertise
Oct 10, 2025 23:25 JST
Anime Tokyo Station: TV Anime 'SPYxFAMILY' Special Exhibition, New Designs Added for Admission Bonus Illustration Cards
Oct 10, 2025 11:30 JST
TANAKA to Provide Medals Expressing Every Runner's Trail through Flowing Curves for the Tokyo Legacy Half Marathon 2025
Oct 10, 2025 03:00 JST
Genequest and Fujitsu uncover new insights into genetics-lifestyle relationships through high-speed, reliable causal AI from Fujitsu Kozuchi
Oct 10, 2025 00:55 JST
Sharp Launches A3 MFPs (BP Series)
Oct 10, 2025 00:50 JST
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony in Shimonoseki for Large Car Ferry HAMANASU
Oct 10, 2025 00:42 JST
Honda Celebrates 30th Anniversary of CR-V
Oct 09, 2025 23:54 JST
DASSAI MOON Project, the World's First Test Brewing of Sake in Space
Oct 09, 2025 23:23 JST
All-New Destinator Wins Gold Award at VMARK Vietnam Design Award 2025
Oct 09, 2025 22:17 JST
Mazda Tests Feasibility of Commercializing Corrosion Resistance Evaluation Service for Coated Components
Oct 09, 2025 21:29 JST
Sumitomo Metal Mining and Toyota Collaborate on Mass Production of Cathode Materials for All-Solid-State Batteries
Oct 09, 2025 20:40 JST
Fujitsu and ARYA develop high-precision AI solution for instant detection of suspicious behavior
Oct 08, 2025 14:39 JST
Toda, JTB and Fujitsu kick off NFT-powered digital transformation project to boost international tourism to Japan
Oct 08, 2025 13:39 JST
Fujitsu and Sony Bank partner to integrate generative AI into core banking system design and development
Oct 08, 2025 13:02 JST
Eisai and Biogen Announce U.S. Availability of LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease
Oct 08, 2025 12:03 JST
More Latest Release >>